Published date: 17 January 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Health services - 85100000
Location of contract
East of England
Value of contract
£2,884,013
Procurement reference
tender_403911/1302643
Published date
17 January 2024
Closing date
5 January 2024
Closing time
5:30pm
Contract start date
1 April 2024
Contract end date
31 March 2025
Contract type
Service contract
Procedure type
Single tender action (below threshold)
A direct contract with a single supplier, without competition.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver the provision of Improving Access to Phycological Therapies (IAPT) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint.
This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037582) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).
In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)
The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £2,884,013.00
As of July 2022, the Integrated Care Board (ICB) superseded the previous 5 CCGs within Mid and South Essex. NHS Mid and South Essex ICB is currently undergoing an organisational restructure and have taken the decision to extend the current contract to the incumbent provider for 12 months whilst commissioning decisions and strategies can be made for the future of this service.
The Authority has taken the decision to award this IAPT to incumbent provider Vita Health Group. The provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients.
The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.
More information
Additional text
-
This contract award notice is made in Find a Tender Service (FTS) and Contracts Finder following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037582) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).
In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)
The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.
The Authority has taken a decision to award a contract to the incumbent provider as it is considered to be the most technically capable provider in the current environment, whilst the ICB undergoes its own procurement process to formally award this service. This award is made to ensure quality, safety and consistency in provision of care that meet the needs of the vulnerable service users and patient population during this transition period.
The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.
Award information
Awarded date
5 January 2024
Contract start date
1 April 2024
Contract end date
31 March 2025
Total value of contract
£2,884,013
This contract was awarded to 1 supplier.
VITA HEALTH GROUP LIMITED
Address
3 Dorset Rise, London, United Kingdom, EC4Y 8EN
Reference
Companies House number: 05002629
Supplier is SME?
Yes
Supplier is VCSE?
No
About the buyer
Contact name
NHS Mid and South Essex Integrated Care Board
Address
Phoenix House, Christopher Martin Rd,
Basildon
SS14 3HG
England
Website
Share this notice
Closing: 5 January 2024, 5:30pm
All content is available under the
